Skip to content

A study to develop blood biomarkers to diagnose patients in depressive state

A study to develop blood biomarkers to diagnose patients in depressive state - A study to develop blood biomarkers to diagnose patients in depressive state

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000011429
Enrollment
200
Registered
2013-08-08
Start date
2013-01-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

National Institute of Radiological Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy subjects: Do not have any psychiatric disorders currently, nor have had similar disorders in the past Able to understand an explanatory document and give consent Patients: Patients in depressive state. Able to understand an explanatory document and give consent

Exclusion criteria

Exclusion criteria: Healthy subjects: Pregnant or possible to become pregnant Currently breastfeeding Have a cardiac pacemaker or other metals in the body, such as brain clip or bolt Participating in other studies involving the use of nuclear medicine within the past 6 months, in terms of radiation safety Other: judged inappropriate as a subject by the investigator Patients: Severe suicidal tendency Presence of other comorbid psychiatric disorders Have taken antidepressants and/or antipsychotic drugs within 1 month prior to the first examination Have organic brain diseases Have current severe physical diseases Pregnant or possible to become pregnant Currently breastfeeding Have a cardiac pacemaker or other metals in the body, such as brain clip or bolt Other: judged inappropriate as a subject by the investigator

Design outcomes

Primary

MeasureTime frame
Prevalence of polymorphism of monoamine-related molecule in patients with depression and healthy volunteers corresponding to change in PET/MRI data and symptom.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026